Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03769376 · ClinicalTrials.gov registry record · NA

Histologic Comparison of Healing After Tooth Extraction With Ridge Preservation Using Two Different Xenografts

A NA study of Partial-edentulism, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
38
Enrollment target
1
Study location

NCT03769376 is a NA study of Partial-edentulism that has completed, run by University of Colorado, Denver. The registered enrollment target is 38 participants, below the 58-participant average among 3 other Partial-edentulism trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03769376, a NA study of Partial-edentulism, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the speed of bone healing of the two most commonly used xenografts on the market, Bio-Oss® and Salvin-Oss® using a tooth extraction ridge preservation model in participants scheduled for tooth extraction and subsequent receipt of a dental implant. Researchers hypothesize that there will be additional vital bone at 16-20 weeks with Salvin-Oss®.

Conditions Studied

Interventions

  • DEVICE Bio-Oss®
  • DEVICE Salvin-Oss®

Study Locations (1)

Colorado

  • University of Colorado School of Dental Medicine - Aurora

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2019-05-22
Est. Completion 2021-03-15
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT03769376

The ClinicalTrials.gov registry entry for NCT03769376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 3 other Partial-edentulism trials with a reported enrollment target (34% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Partial-edentulism appearing as the primary indexed condition, and to 2 interventions - of which Bio-Oss® is the first listed.

NCT03769376 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT03769376 about?

NCT03769376 is a clinical study titled "Histologic Comparison of Healing After Tooth Extraction With Ridge Preservation Using Two Different Xenografts". The purpose of this study is to compare the speed of bone healing of the two most commonly used xenografts on the market, Bio-Oss® and Salvin-Oss® using a tooth extraction ridge preservation model in participants scheduled for tooth extraction and subsequent receipt of a dental implant. Researchers ...

What is the current status of trial NCT03769376?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-05-22. Estimated completion is 2021-03-15.

What conditions does trial NCT03769376 study?

This clinical trial studies the following conditions: Partial-edentulism.

What interventions are being tested in trial NCT03769376?

The interventions under investigation include: Bio-Oss® (DEVICE), Salvin-Oss® (DEVICE).

Who is sponsoring clinical trial NCT03769376?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03769376 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Partial-edentulism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.